Solaxa

Bethesda, United States

Solaxa is a neuro-regenerative startup that develops novel and reformulated drugs to restore nerve function by targeting ion channels.

$670K raised

May 2024

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Solaxa

How much funding has Solaxa raised?

Solaxa has raised $670K in total funding. The most recent round was Seed. The last funding was announced in May 2024.

Where is Solaxa headquartered?

Solaxa is headquartered in Bethesda, United States.

What does Solaxa do?

Solaxa is a neuro-regenerative startup that develops novel and reformulated drugs to restore nerve function by targeting ion channels.

What stage is Solaxa at?

Solaxa is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 3, 2024.

MLA

"Solaxa — Funding & Investors." VCBacked, May 3, 2024, https://www.vcbacked.co/company/solaxa. Accessed July 2, 2026.

APA

VCBacked. (2024). Solaxa — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/solaxa

Wikipedia (cite web)

{{cite web |title=Solaxa — Funding & Investors |url=https://www.vcbacked.co/company/solaxa |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 3, 2024.